| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |